The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
ACE2, angiotensin‐(1‐7) and Mas receptor axis in inflammation and fibrosis
Open accessAbstract
Recent advances have improved our understanding of the renin‐angiotensin system (RAS). These have included the recognition that angiotensin (A ng)‐(1‐7) is a biologically active product of the RAS cascade. The identification of the ACE homologue ACE2, which forms A ng‐(1‐7) from A ng II, and the GPCR M as as an A ng‐(1‐7) receptor have provided the necessary biochemical and molecular background and tools to study the biological significance of A ng‐(1‐7). Most available evidence supports a counter‐regulatory role for A ng‐(1‐7) by opposing many actions of A ng II on AT 1 receptors, especially vasoconstriction and proliferation. Many studies have now shown that A ng‐(1‐7) by acting via M as receptor exerts inhibitory effects on inflammation and on vascular and cellular growth mechanisms. A ng‐(1‐7) has also been shown to reduce key signalling pathways and molecules thought to be relevant for fibrogenesis. Here, we review recent findings related to the function of the ACE2/A ng‐(1‐7)/M as axis and focus on the role of this axis in modifying processes associated with acute and chronic inflammation, including leukocyte influx, fibrogenesis and proliferation of certain cell types. More attention will be given to the involvement of the ACE2/A ng‐(1‐7)/M as axis in the context of renal disease because of the known relevance of the RAS for the function of this organ and for the regulation of kidney inflammation and fibrosis. Taken together, this knowledge may help in paving the way for the development of novel treatments for chronic inflammatory and renal diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Making sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08090-x · Cited by 1,560
Sadoshima, J., & Izumo, S. (1993) · Circulation Research · doi:10.1161/01.res.73.3.413 · Cited by 1,427
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Inflammation and angiotensin II
Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., & Egido, J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00271-6 · Cited by 694
TGF-?1 and angiotensin networking in cardiac remodeling
ROSENKRANZ, S. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.030 · Cited by 683
Ye, M., Wysocki, J., William, J., Soler, M. J., Cokic, I., & Batlle, D. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050423 · Cited by 485
Zhong, J., Basu, R., Guo, D., Chow, F. L., Byrns, S., Schuster, M., Loibner, H., Wang, X.-H., Penninger, J. M., Kassiri, Z., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.955369 · Cited by 457
Gray, M. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00121-7 · Cited by 417
G-Protein–Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor
Kostenis, E., Milligan, G., Christopoulos, A., Sanchez-Ferrer, C. F., Heringer-Walther, S., Sexton, P. M., Gembardt, F., Kellett, E., Martini, L., Vanderheyden, P., et al. (2005) · Circulation · doi:10.1161/01.cir.0000160867.23556.7d · Cited by 415
Proinflammatory actions of angiotensins
Ruiz-Ortega, M., Lorenzo, O., Suzuki, Y., Rupérez, M., & Egido, J. (2001) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200105000-00005 · Cited by 412
Angiotensin-converting enzyme 2 in lung diseases
KUBA, K., IMAI, Y., & PENNINGER, J. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.03.001 · Cited by 401
Renin–angiotensin–aldosterone system blockade for cardiovascular diseases: current status
Ma, T. K., Kam, K. K., Yan, B. P., & Lam, Y. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00750.x · Cited by 364
Campbell, S. E., & Katwa, L. C. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0435 · Cited by 357
Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases
Ruiz-Ortega, M., Rupérez, M., Esteban, V., Rodríguez-Vita, J., Sánchez-López, E., Carvajal, G., & Egido, J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi265 · Cited by 356
ACE and ACE2 Activity in Diabetic Mice
Wysocki, J., Ye, M., Soler, M. J., Gurley, S. B., Xiao, H. D., Bernstein, K. E., Coffman, T. M., Chen, S., & Batlle, D. (2006) · Diabetes · doi:10.2337/db06-0033 · Cited by 339
Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1–7)
Grobe, J. L., Mecca, A. P., Lingis, M., Shenoy, V., Bolton, T. A., Machado, J. M., Speth, R. C., Raizada, M. K., & Katovich, M. J. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00937.2006 · Cited by 332
Yamamoto, K., Ohishi, M., Katsuya, T., Ito, N., Ikushima, M., Kaibe, M., Tatara, Y., Shiota, A., Sugano, S., Takeda, S., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000205833.89478.5b · Cited by 323
Angiotensin-(1–7) inhibits growth of cardiac myocytes through activation of the mas receptor
Tallant, E. A., Ferrario, C. M., & Gallagher, P. E. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00941.2004 · Cited by 318
Emerging mechanisms of neutrophil recruitment across endothelium
Williams, M. R., Azcutia, V., Newton, G., Alcaide, P., & Luscinskas, F. W. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.009 · Cited by 306
Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
Oudit, G. Y., Liu, G. C., Zhong, J., Basu, R., Chow, F. L., Zhou, J., Loibner, H., Janzek, E., Schuster, M., Penninger, J. M., et al. (2010) · Diabetes · doi:10.2337/db09-1218 · Cited by 300
Metabolism of Angiotensin-(1–7) by Angiotensin-Converting Enzyme
Chappell, M. C., Pirro, N. T., Sykes, A., & Ferrario, C. M. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.362 · Cited by 289
Schiavone, M. T., Santos, R. A., Brosnihan, K. B., Khosla, M. C., & Ferrario, C. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4095 · Cited by 288
Santos, R. A. S., Campagnole-Santos, M. J., Baracho, N. C. V., Fontes, M. A. P., Silva, L. C. S., Neves, L. A. A., R. Oliveira, D., Caligiorne, S. M., Rodrigues, A. R. V., Gropen, C., et al. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90104-x · Cited by 286
Angiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells
Sampaio, W. O., Henrique de Castro, C., Santos, R. A. S., Schiffrin, E. L., & Touyz, R. M. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.084848 · Cited by 283
Shenoy, V., Ferreira, A. J., Qi, Y., Fraga-Silva, R. A., Díez-Freire, C., Dooies, A., Jun, J. Y., Sriramula, S., Mariappan, N., Pourang, D., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1840oc · Cited by 281
Self-citationThe Physiology of Leukocyte Recruitment: An In Vivo Perspective
Petri, B., Phillipson, M., & Kubes, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6439 · Cited by 278
Loss of Angiotensin-Converting Enzyme-2 (Ace2) Accelerates Diabetic Kidney Injury
Wong, D. W., Oudit, G. Y., Reich, H., Kassiri, Z., Zhou, J., Liu, Q. C., Backx, P. H., Penninger, J. M., Herzenberg, A. M., & Scholey, J. W. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060977 · Cited by 273
Hernández Prada, J. A., Ferreira, A. J., Katovich, M. J., Shenoy, V., Qi, Y., Santos, R. A. S., Castellano, R. K., Lampkins, A. J., Gubala, V., Ostrov, D. A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.108944 · Cited by 271
Self-citationFerrario, C. M., Jessup, J., Gallagher, P. E., Averill, D. B., Brosnihan, K. B., Ann Tallant, E., Smith, R. D., & Chappell, M. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00675.x · Cited by 259
Liu, J., Ji, H., Zheng, W., Wu, X., Zhu, J. J., Arnold, A. P., & Sandberg, K. (2010) · Biology of Sex Differences · doi:10.1186/2042-6410-1-6 · Cited by 246
Ferreira, A. J., Shenoy, V., Yamazato, Y., Sriramula, S., Francis, J., Yuan, L., Castellano, R. K., Ostrov, D. A., Oh, S. P., Katovich, M. J., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200811-1678oc · Cited by 245
Self-citationOUDIT, G., KASSIRI, Z., PATEL, M., CHAPPELL, M., BUTANY, J., BACKX, P., TSUSHIMA, R., SCHOLEY, J., KHOKHA, R., & PENNINGER, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.007 · Cited by 245
Angiotensin II, Transforming Growth Factor-β1and Repair in the Infarcted Heart
Sun, Y. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0721 · Cited by 240
Recent advances in angiotensin II signaling
Touyz, R. M., & Berry, C. (2002) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2002000900001 · Cited by 239
Huentelman, M. J., Grobe, J. L., Vazquez, J., Stewart, J. M., Mecca, A. P., Katovich, M. J., Ferrario, C. M., & Raizada, M. K. (2005) · Experimental Physiology · doi:10.1113/expphysiol.2005.031096 · Cited by 237
Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice
Santos, R. A. S., Castro, C. H., Gava, E., Pinheiro, S. V. B., Almeida, A. P., de Paula, R. D., Cruz, J. S., Ramos, A. S., Rosa, K. T., Irigoyen, M. C., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000215289.51180.5c · Cited by 237
Self-citationOudit, G. Y., Herzenberg, A. M., Kassiri, Z., Wong, D., Reich, H., Khokha, R., Crackower, M. A., Backx, P. H., Penninger, J. M., & Scholey, J. W. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051091 · Cited by 232
Thomas, M. C., Pickering, R. J., Tsorotes, D., Koitka, A., Sheehy, K., Bernardi, S., Toffoli, B., Nguyen-Huu, T.-P., Head, G. A., Fu, Y., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.219279 · Cited by 232
Iwata, M., Cowling, R. T., Gurantz, D., Moore, C., Zhang, S., Yuan, J. X.-J., & Greenberg, B. H. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00317.2005 · Cited by 231
Luque, M., Martin, P., Martell, N., Fernandez, C., Brosnihan, K. B., & Ferrario, C. M. (1996) · Journal of Hypertension · doi:10.1097/00004872-199606000-00017 · Cited by 230
Iyer, S. N., Ferrario, C. M., & Chappell, M. C. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.356 · Cited by 228
Iyer, S. N., Chappell, M. C., Averill, D. B., Diz, D. I., & Ferrario, C. M. (1998) · Hypertension · doi:10.1161/01.hyp.31.2.699 · Cited by 227
Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart
Mercure, C., Yogi, A., Callera, G. E., Aranha, A. B., Bader, M., Ferreira, A. J., Santos, R. A. S., Walther, T., Touyz, R. M., & Reudelhuber, T. L. (2008) · Circulation Research · doi:10.1161/circresaha.108.184911 · Cited by 226
Self-citationKassiri, Z., Zhong, J., Guo, D., Basu, R., Wang, X., Liu, P. P., Scholey, J. W., Penninger, J. M., & Oudit, G. Y. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.840124 · Cited by 226
Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats
Benter, I. F., Ferrario, C. M., Morris, M., & Diz, D. I. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.1.h313 · Cited by 225
Vasodilator Action of Angiotensin-(1-7) on Isolated Rabbit Afferent Arterioles
Ren, Y., Garvin, J. L., & Carretero, O. A. (2002) · Hypertension · doi:10.1161/hy0302.104673 · Cited by 223
Soler, M. J., Wysocki, J., Ye, M., Lloveras, J., Kanwar, Y., & Batlle, D. (2007) · Kidney International · doi:10.1038/sj.ki.5002373 · Cited by 217
Benter, I. F., Yousif, M. H. M., Dhaunsi, G. S., Kaur, J., Chappell, M. C., & Diz, D. I. (2008) · American Journal of Nephrology · doi:10.1159/000108758 · Cited by 204
Cardiovascular actions of angiotensin(1–7)
Benter, I. F., Diz, D. I., & Ferrario, C. M. (1993) · Peptides · doi:10.1016/0196-9781(93)90097-z · Cited by 201
Azizi, M., & Ménard, J. (2004) · Circulation · doi:10.1161/01.cir.0000131449.94713.ad · Cited by 199
AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1–7) on the Endothelium
Wiemer, G., Dobrucki, L. W., Louka, F. R., Malinski, T., & Heitsch, H. (2002) · Hypertension · doi:10.1161/01.hyp.0000037979.53963.8f · Cited by 199
Su, Z., Zimpelmann, J., & Burns, K. D. (2006) · Kidney International · doi:10.1038/sj.ki.5001509 · Cited by 196
Systemic and regional hemodynamic effects of angiotensin-(1–7) in rats
Sampaio, W. O., Nascimento, A. A. S., & Santos, R. A. S. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01145.2002 · Cited by 191
Santos, R. A. S., Ferreira, A. J., Nadu, A. P., Braga, A. N. G., de Almeida, A. P., Campagnole-Santos, M. J., Baltatu, O., Iliescu, R., Reudelhuber, T. L., & Bader, M. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00227.2003 · Cited by 187
Self-citationACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension
Sriramula, S., Cardinale, J. P., Lazartigues, E., & Francis, J. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr242 · Cited by 186
Li, X., Molina-Molina, M., Abdul-Hafez, A., Uhal, V., Xaubet, A., & Uhal, B. D. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00009.2008 · Cited by 182
Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney
Pinheiro, S. V. B., Simões e Silva, A. C., Sampaio, W. O., de Paula, R. D., Mendes, E. P., Bontempo, E. D., Pesquero, J. B., Walther, T., Alenina, N., Bader, M., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000141438.64887.42 · Cited by 175
Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats
Campagnole-Santos, M. J., Diz, D. I., Santos, R. A., Khosla, M. C., Brosnihan, K. B., & Ferrario, C. M. (1989) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1989.257.1.h324 · Cited by 171
da Silveira, K. D., Coelho, F. M., Vieira, A. T., Sachs, D., Barroso, L. C., Costa, V. V., Bretas, T. L. B., Bader, M., de Sousa, L. P., da Silva, T. A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000314 · Cited by 170
Self-citationAngiotensin-(1–7) prevents diabetes-induced cardiovascular dysfunction
Benter, I. F., Yousif, M. H. M., Cojocel, C., Al-Maghrebi, M., & Diz, D. I. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00372.2006 · Cited by 167
Molecular Mechanisms of Inhibition of Vascular Growth by Angiotensin-(1-7)
Tallant, E. A., & Clark, M. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000090322.55782.30 · Cited by 167
Cardiovascular actions of angiotensin-(1-7)
Ferreira, A. J., & Santos, R. A. S. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005000400003 · Cited by 165
Self-citationInhibition of human lung cancer cell growth by angiotensin-(1-7)
Gallagher, P. E. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh236 · Cited by 165
Kidneys and fluids in pressure regulation. Small volume but large pressure changes.
Guyton, A. C. (1992) · Hypertension · doi:10.1161/01.hyp.19.1_suppl.i2 · Cited by 164
ACE2: more of Ang-(1–7) or less Ang II?
Ferrario, C. M. (2011) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e3283406f57 · Cited by 164
Piqueras, L., Kubes, P., Alvarez, A., O’Connor, E., Issekutz, A. C., Esplugues, J. V., & Sanz, M.-J. (2000) · Circulation · doi:10.1161/01.cir.102.17.2118 · Cited by 161
El‐Hashim, A. Z., Renno, W. M., Raghupathy, R., Abduo, H., Akhtar, S., & Benter, I. F. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01905.x · Cited by 160
Role of Renin-Angiotensin System in Inflammation, Immunity and Aging
Capettini, L. D. S. A., Montecucco, F., Mach, F., Stergiopulos, N., Santos, R. A. S., & da Silva, R. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799436593 · Cited by 160
Pinheiro, S. V. B., Ferreira, A. J., Kitten, G. T., da Silveira, K. D., da Silva, D. A., Santos, S. H. S., Gava, E., Castro, C. H., Magalhães, J. A., da Mota, R. K., et al. (2009) · Kidney International · doi:10.1038/ki.2009.61 · Cited by 157
Self-citationEffects of renin-angiotensin system inhibition end-organ protection: Can we do better?
WEIR, M. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.019 · Cited by 156
Natriuretic action of angiotensin(1–7)
DelliPizzi, A., Hilchey, S. D., & Quilley, C. P. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14014.x · Cited by 154
Jiang, T., Gao, L., Guo, J., Lu, J., Wang, Y., & Zhang, Y. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02105.x · Cited by 152
Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis
Libby, P. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800099-jlr200 · Cited by 147
Sarkissian, S. D., Grobe, J. L., Yuan, L., Narielwala, D. R., Walter, G. A., Katovich, M. J., & Raizada, M. K. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100693 · Cited by 144
Prevention of Pulmonary Hypertension by Angiotensin-Converting Enzyme 2 Gene Transfer
Yamazato, Y., Ferreira, A. J., Hong, K., Sriramula, S., Francis, J., Yamazato, M., Yuan, L., Bradford, C., Shenoy, V., Oh, S. P., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.125468 · Cited by 142
Self-citationAngiotensin-(1–7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal Inflammation
Esteban, V., Heringer‐Walther, S., Sterner‐Kock, A., de Bruin, R., van den Engel, S., Wang, Y., Mezzano, S. A., Egido, J., Schultheiss, H., Ruiz‐Ortega, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005406 · Cited by 141
Yu, C., Tipoe, G. L., Lai, K. W.-H., & Lau, C. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01518-2 · Cited by 136
Angiotensin signalling in pulmonary fibrosis
Uhal, B. D., Li, X., Piasecki, C. C., & Molina‐Molina, M. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.11.019 · Cited by 128
Anti-Inflammatory Effects of Angiotensin Receptor Blockers in the Brain and the Periphery
Benický, J., Sánchez-Lemus, E., Pavel, J., & Saavedra, J. M. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9368-4 · Cited by 126
Sukumaran, V., Veeraveedu, P. T., Gurusamy, N., Yamaguchi, K., Lakshmanan, A. P., Ma, M., Suzuki, K., Kodama, M., & Watanabe, K. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1077 · Cited by 126
Nabah, Y. N. A., Mateo, T., Estellés, R., Mata, M., Zagorski, J., Sarau, H., Cortijo, J., Morcillo, E. J., Jose, P. J., & Sanz, M.-J. (2004) · Circulation · doi:10.1161/01.cir.0000148824.93600.f3 · Cited by 124
Role of integrin-mediated TGFβ activation in the pathogenesis of pulmonary fibrosis
Goodwin, A. T., & Jenkins, G. R. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370849 · Cited by 122
Owen, C. A., & Campbell, E. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1436 · Cited by 121
Effect of ACE2 and angiotensin-(1–7) in a mouse model of early chronic kidney disease
Dilauro, M., Zimpelmann, J., Robertson, S. J., Genest, D. S., & Burns, K. D. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00426.2009 · Cited by 120
Ji, H., Menini, S., Zheng, W., Pesce, C. M., Wu, X., & Sandberg, K. L. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.041392 · Cited by 116
Liu, Z., Huang, X. R., Chen, H., Penninger, J. M., & Lan, H. Y. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.2 · Cited by 115
Angiotensin 1-7 has a biphasic effect on fluid absorption in the proximal straight tubule.
Garcia, N. H., & Garvin, J. L. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v541133 · Cited by 115
Characterization of Angiotensin-(1-7) in the Urine of Normal and Essential Hypertensive Subjects
Ferrario, C. M. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00400-7 · Cited by 114
Neutrophil‐active chemokines in in vivo imaging of neutrophil trafficking
Sanz, M., & Kubes, P. (2012) · European Journal of Immunology · doi:10.1002/eji.201142231 · Cited by 114
Differential actions of renal ischemic injury on the intrarenal angiotensin system
Allred, A. J., Chappell, M. C., Ferrario, C. M., & Diz, D. I. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.4.f636 · Cited by 113
Ferreira, A. J., Shenoy, V., Qi, Y., Fraga-Silva, R. A., Santos, R. A. S., Katovich, M. J., & Raizada, M. K. (2010) · Experimental Physiology · doi:10.1113/expphysiol.2010.055277 · Cited by 112
Self-citationAngiotensin-(1–7) in kidney disease: a review of the controversies
Zimmerman, D. L., & Burns, K. D. (2012) · Clinical Science · doi:10.1042/cs20120111 · Cited by 111
Evidence for a Physiological Role of Angiotensin-(1-7) in the Control of Hydroelectrolyte Balance
Santos, R. A. S., Silva, A. C. S. E., Magaldi, A. J., et al. (1996) · Hypertension · doi:10.1161/01.hyp.27.4.875 · Cited by 110
Angiotensin‐(1–7) decreases LPS‐induced inflammatory response in macrophages
Souza, L. L., & Costa-Neto, C. M. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22940 · Cited by 109
Pereira, R. M., Santos, R. A. S., Teixeira, M. M., Leite, V. H. R., Costa, L. P., Dias, F. L. D. C., Barcelos, L. S., Collares, G. B., & Silva, A. C. S. E. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.018 · Cited by 108
Self-citationChappell, M. C., Modrall, J. G., Diz, D. I., & Ferrario, C. M. (2004) · KARGER eBooks · doi:10.1159/000078713 · Cited by 105
The renin-angiotensin system: importance in physiology and pathology.
Ferrario, C. M. (1990) · PubMed · Cited by 102
Mateo, T., Nabah, Y. N. A., Abu-Taha, M. I., Mata, M., Cerdá‐Nicolás, M., Proudfoot, A. E. I., Stahl, R. A. K., Issekutz, A. C., Cortijo, J., Morcillo, E. J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5577 · Cited by 98
Lubel, J. S., Herath, C. B., Tchongue, J., Grace, J., Jia, Z., Spencer, K., CASLEY, D. J., Crowley, P. F., Sievert, W., Burrell, L. M., et al. (2009) · Clinical Science · doi:10.1042/cs20080647 · Cited by 95
Role of Angiotensin-(1-7) in the Modulation of the Baroreflex in Renovascular Hypertensive Rats
Britto, R. R., Santos, R. A. S., Fagundes-Moura, C. R., et al. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.549 · Cited by 93
Ferrario, C. M. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199000153-00001 · Cited by 93
Atherosclerosis in chronic kidney disease: the role of macrophages
Kon, V., Linton, M. F., & Fazio, S. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.157 · Cited by 90
Characterization of a New Selective Antagonist for Angiotensin-(1–7), d -Pro 7 -Angiotensin-(1–7)
Santos, R. A. S., Haibara, A. S., Campagnole‐Santos, M. J., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000052947.60363.24 · Cited by 89
Angiotensin-(1-7) and the Rat Aorta: Modulation by the Endothelium
le Tran, Y., & Forster, C. M. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199711000-00019 · Cited by 89
Moon, J.-Y., Tanimoto, M., Gohda, T., Hagiwara, S., Yamazaki, T., Ohara, I., Murakoshi, M., Aoki, T., Ishikawa, Y., Lee, S.-H., et al. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00065.2010 · Cited by 88
Santiago, N. M., Guimarães, P. S., Sirvente, R. A., Oliveira, L. A. M., Irigoyen, M. C., Santos, R. A. S., & Campagnole‐Santos, M. J. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.149815 · Cited by 86
McCollum, L. T., Gallagher, P. E., & Tallant, E. A. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00908.2011 · Cited by 86
Gava, E., Samad-Zadeh, A., Zimpelmann, J., Bahramifarid, N., Kitten, G. T., Santos, R. A. S., Touyz, R. M., & Burns, K. D. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn736 · Cited by 84
Ferreira, A. J., Murça, T. M., Fraga-Silva, R. A., Castro, C. H., Raizada, M. K., & Santos, R. A. S. (2012) · International Journal of Hypertension · doi:10.1155/2012/147825 · Cited by 83
Self-citationJin, H., Song, B., Oudit, G. Y., Davidge, S. T., Yu, H., Jiang, Y., Gao, P., Zhu, D., Ning, G., Kassiri, Z., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038502 · Cited by 83
Pathways of angiotensin‐(1–7) metabolism in the kidney
Chappell, M. C., Allred, A. J., & Ferrario, C. M. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_1.22 · Cited by 83
Angiotensin-(1–7) activates growth-stimulatory pathways in human mesangial cells
Zimpelmann, J., & Burns, K. D. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90437.2008 · Cited by 83
Angiotensin-(1–7) attenuates diabetic nephropathy in Zucker diabetic fatty rats
Giani, J. F., Burghi, V., Veiras, L. C., Tomat, A. L., Muñoz, M. C., Cao, G., Turyn, D., Toblli, J. E., & Dominici, F. P. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00063.2012 · Cited by 80
Chronic Exercise Preserves Renal Structure and Hemodynamics in Spontaneously Hypertensive Rats
Agarwal, D., Elks, C. M., Reed, S. D., Mariappan, N., Majid, D. S. A., & Francis, J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3967 · Cited by 79
Zhang, J., Noble, N. A., Border, W. A., & Huang, Y. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00548.2009 · Cited by 79
The renin–angiotensin–aldosterone system in 2011: role in hypertension and chronic kidney disease
Silva, A. C. S. E., & Flynn, J. T. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-2002-y · Cited by 78
Interactions Between Angiotensin-(1-7), Kinins, and Angiotensin II in Kidney and Blood Vessels
Santos, R. A. S., Passaglio, K. T., Pesquero, J. B., et al. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.660 · Cited by 78
Magaldi, A. J., César, K. R., de Araújo, M., et al. (2003) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1173-1 · Cited by 76
Velkoska, E., Dean, R. G., Griggs, K., Burchill, L. J., & Burrell, L. M. (2010) · Clinical Science · doi:10.1042/cs20100280 · Cited by 73
Giani, J. F., Muñoz, M. C., Pons, R. A., et al. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00278.2010 · Cited by 73
Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension
Ferrario, C. M., Smith, R. D., Brosnihan, B., Chappell, M. C., Campese, V. M., Vesterqvist, O., Liao, W., Ruddy, M. C., & Grim, C. E. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02268-9 · Cited by 73
Lara, L. S., Cavalcante, F., Axelband, F., Souza, A. M. D., Lopes, A. G., & Caruso‐Neves, C. (2006) · Biochemical Journal · doi:10.1042/bj20051455 · Cited by 72
Santos, G. A. B., Sampaio, W. O., Reudelhuber, T. L., Bäder, M., Campagnole‐Santos, M. J., & Santos, R. A. S. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01245.2006 · Cited by 69
Silva, A. C. S. E., Diniz, J. S. S., Filho, A. R., & Santos, R. A. S. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.03.055 · Cited by 68
Marques, F. D., Melo, M. B., de Souza, L. E., Irigoyen, M. C., Sinisterra, R. D., Sousa, F. B. D., Savergnini, S. Q., Braga, V. B. A., Ferreira, A. J., & Santos, R. A. S. (2012) · International Journal of Hypertension · doi:10.1155/2012/795452 · Cited by 67
Self-citationBarroso, L. C., da Silveira, K. D., Lima, C. X., Borges, V. O., Bäder, M., Rachid, M. A., Santos, R. A. S., Souza, D. G., Silva, A. C. S. E., & Teixeira, M. M. (2012) · International Journal of Hypertension · doi:10.1155/2012/808726 · Cited by 65
Self-citationDavie, A. P., & McMurray, J. J. V. (1999) · Hypertension · doi:10.1161/01.hyp.34.3.457 · Cited by 65
(1990) · PubMed · Cited by 64
Lo, C., Liu, F., Shi, Y., Maachi, H., Chénier, I., Godin, N., Filep, J. G., Ingelfinger, J. R., Zhang, S., & Chan, J. S. D. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00340.2011 · Cited by 62
Liu, G. C., Oudit, G. Y., Fang, F., Zhou, J., & Scholey, J. W. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00455.2011 · Cited by 61
Angiotensin-(1-7) is a potent antidiuretic peptide in rats.
Santos, R. A. S., & Baracho, N. C. V. (1992) · PubMed · Cited by 58
Ferreira, A. J., Castro, C. H., Guatimosim, S., et al. (2010) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944709353426 · Cited by 56
Self-citationSukumaran, V., Veeraveedu, P. T., Gurusamy, N., Lakshmanan, A. P., Yamaguchi, K., Ma, M., Suzuki, K., Kodama, M., & Watanabe, K. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.11.018 · Cited by 55
Nabah, Y. N. A., Losada, M., Estellés, R., Mateo, T., Piqueras, L., López‐Ginés, C., Sarau, H. M., Cortijo, J., Morcillo, E. J., Jose, P. J., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.147009 · Cited by 55
Angiotensin-(1–7) attenuates hypertension in exercise-trained renal hypertensive rats
Shah, A., Oh, Y., Lee, S. H., Lim, J. M., & Kim, S. H. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00846.2011 · Cited by 54
Effect of Intratubular Application of Angiotensin 1-7 on Nephron Function
Vallon, V., Richter, K., Heyne, N., et al. (1997) · Kidney & Blood Pressure Research · doi:10.1159/000174151 · Cited by 53
Stegbauer, J. (2003) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.017 · Cited by 51
Differential actions of angiotensin-(1-7) in the kidney
Chappell, M. C., Diz, D. I., Yunis, C., et al. (1998) · Kidney International · doi:10.1038/sj.ki.4490555 · Cited by 48
Gava, E., Castro, C. H., Ferreira, A. J., Colleta, H. H. M. D., Melo, M. B., Alenina, N. V., Bäder, M., Oliveira, L. A. M., Santos, R. A. S., & Kitten, G. T. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2012.01.001 · Cited by 47
Self-citationLi, Y. H., Wu, J., He, Q., Shou, Z., Zhang, P., Pen, W., Zhu, Y., & Chen, J. (2009) · Hypertension Research · doi:10.1038/hr.2009.25 · Cited by 47
Yong-jun, G., Li, W., Wu, R., Xie, Q., & Cui, L. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.07.010 · Cited by 47
Kocks, M. J. A., Lely, A. T., Boomsma, F., de Jong, P. E., & Navis, G. J. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000160217.86597.b6 · Cited by 46
Shenoy, V., Grobe, J. L., Qi, Y., Ferreira, A. J., Fraga‐Silva, R. A., Collamat, G., Bruce, E., & Katovich, M. J. (2009) · Peptides · doi:10.1016/j.peptides.2009.09.005 · Cited by 46
Self-citationXue, H., Zhou, L., Yuan, P., Wang, Z., Ni, J., Yao, T., Wang, J., Huang, Y., Yu, C., & Lü, L. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2012.04.002 · Cited by 44
Zeng, W., Chen, W., Leng, X., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.112 · Cited by 44
The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetes
Nogueira, A. I., Santos, R. A. S., Silva, A. C. S. E., Cabral, A. C. V., Vieira, R. L. P., Drumond, T. C., Machado, L. J. D. C., Freire, C. M. V., & Ribeiro‐Oliveira, A. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2006.12.014 · Cited by 44
Renal actions of angiotensin-(1-7)
Silva, A. C. S. E., Baracho, N. C. D. V., Passaglio, K. T., & Santos, R. A. S. (1997) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1997000400012 · Cited by 43
Bürgelová, M., Kramer, H. J., Teplan, V., et al. (2002) · Kidney & Blood Pressure Research · doi:10.1159/000066340 · Cited by 41
Vilas-Boas, W. W., Ribeiro‐Oliveira, A., Pereira, R. M., et al. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2512 · Cited by 41
Nakamura, K., Koibuchi, N., Nishimatsu, H., Higashikuni, Y., Hirata, Y., Kugiyama, K., Nagai, R., & Sata, M. (2008) · Hypertension Research · doi:10.1291/hypres.31.1953 · Cited by 38
Renal function in transgenic rats expressing an angiotensin-(1–7)-producing fusion protein
Ferreira, A. J., Pinheiro, S. V. B., Castro, C. H., et al. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.06.005 · Cited by 37
Self-citationBaracho, N. C. V., Silva, A. C. S. E., Khosla, M. C., et al. (1998) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1998000900016 · Cited by 35
Piqueras, L., Nabah, Y. N. A., Escudero, P., Blanes, J. I., Jose, P. J., Morcillo, E. J., & Sanz, M. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr147 · Cited by 34
Nadu, A. P., Ferreira, A. J., Reudelhuber, T. L., et al. (2008) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2008.04.012 · Cited by 33
Self-citationRenal protection with angiotensin receptor blockers: where do we stand
Schmieder, R. E., Ruilope, L. M., & Barnett, A. H. (2011) · Journal of Nephrology · doi:10.5301/jn.2011.6445 · Cited by 28
The Renoprotective Actions of Peroxisome Proliferator-Activated Receptors Agonists in Diabetes
Thomas, M. C., Jandeleit-Dahm, K. A. M., & Tikellis, C. (2012) · PPAR Research · doi:10.1155/2012/456529 · Cited by 22
Powers, B. J., Greene, L., & Balfe, L. M. (2011) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2011.17.s8.1 · Cited by 19
Sensing sterile injury: Opportunities for pharmacological control
Menezes, G. B., Mansur, D. S., McDonald, B., Kubes, P., & Teixeira, M. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.07.002 · Cited by 17
Self-citationAdvantages of renin-angiotensin system blockade in the treatment of cardiovascular diseases.
Gerc, V., & Buksa, M. (2010) · PubMed · Cited by 11
Tocci, G., & Volpe, M. (2011) · Drugs · doi:10.2165/11591350-000000000-00000 · Cited by 10
Cited by
Endocrine and metabolic link to coronavirus infection
Bornstein, S. R., Dalan, R., Hopkins, D., Mingrone, G., & Boehm, B. O. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0353-9 · Cited by 366
ACE2, Much More Than Just a Receptor for SARS-COV-2
Samavati, L., & Uhal, B. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00317 · Cited by 364
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Zamorano Cuervo, N., & Grandvaux, N. (2020) · eLife · doi:10.7554/elife.61390 · Cited by 313
Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease
Jia, H. (2016) · Shock · doi:10.1097/shk.0000000000000633 · Cited by 294
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Gusev, E., Sarapultsev, A., Solomatina, L., & Chereshnev, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031716 · Cited by 281
Metadata
- Authors
- Simões e Silva, A., Silveira, K., Ferreira, A., & Teixeira, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2013-05-16
- Volume
- 169
- Issue
- 3
- Pages
- 477-492
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2138043907
- Cited by
- 542
- References
- 167
- FWCI
- 14.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.